HES1 and neoplasm: It is noteworthy that Hes1 knockout mice exhibited more significant suppression of tumor growth following treatment with combined immune checkpoint inhibitors, such as anti-PD-1 antibodies (88), further highlighting the potential of Hes1 as a synergistic target in immunotherapy.